About Us
Company History Management Team Qualifications Development
R&D Innovation
Innovative therapy Cell Production Cell Testing IUR Team of scientists
Immune Cells
Tcm CAPRI
Pipeline
Pipeline Pipeline Products
Business
Patient-centered
Clinical Recruitment Test Guide FAQ
News
Company News Media Announcement
Careers
Talent Concept Job Opportunities Staff Presence Employee Development
Global

中文简体 中文繁体 English

Home
About Us

Company History Management Team Qualifications Development

R&D Innovation

Innovative therapy Cell Production Cell Testing IUR Team of scientists

Immune Cells

Overview Tcm CAPRI

Pipeline

Pipeline Pipeline Products

Business
Patient-centered

Clinical Recruitment Test Guide FAQ

News

Company News Media Announcement

Careers
Global

中文简体 中文繁体 English

Clinical Recruitment Illuminate the light of hope for patients
Home Patient-centered Clinical Recruitment
Clinical Recruitment Test Guide FAQ
SDT-T001 Injection: Recruiting Postoperative Liver Cancer Patients in Multiple Centers Nationwide The randomized, controlled, open label, multicenter phase II clinical trial of SDT-T001 for adjuvant therapy in patients with high recurrence risk after radical resection of primary hepatocellular carcinoma, sponsored by Cytocraft is recruiting participants. 2025-06-18
More
 SDTM001 Injection: Recruiting Postoperative Patients with Non Small Cell Lung Cancer in Multiple Centers Nationwide Sedet Biotech is conducting a phase clinical trial (protocol number: SDTM001-2024) of SDTM001 injection as adjuvant therapy for non-small-cell lung cancer (NSCLC) patients with negative driver gene mutations and PD-L1 expression after surgical resection. 2025-05-27
More

WeChat QR code

© 2026 Cytocraft 滇ICP备19000249号-1 Powered by SE

This website uses cookies to provide you with a personalized browsing experience and analyze website traffic. By clicking 'Accept', you agree to our use of cookies.